Scarica l'app Stockscreener
15.22
1.26%
0.19
Dopo l'orario di chiusura:
15.22
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KROS Giù?
Forum
Previsione
Precedente Chiudi:
$15.03
Aprire:
$15.05
Volume 24 ore:
666.20K
Relative Volume:
1.05
Capitalizzazione di mercato:
$618.17M
Reddito:
-
Utile/perdita netta:
$-168.05M
Rapporto P/E:
-2.9669
EPS:
-5.13
Flusso di cassa netto:
$-146.15M
1 W Prestazione:
+1.20%
1M Prestazione:
-3.79%
6M Prestazione:
+5.40%
1 anno Prestazione:
-73.78%
Intervallo 1D:
$14.86
$15.29
Intervallo di 1 settimana:
$14.77
$15.54
Portata 52W:
$9.12
$72.37
Keros Therapeutics Inc Stock (KROS) Company Profile
Nome
Keros Therapeutics Inc
Settore
Industria
Telefono
617-314-6297
Indirizzo
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA
Confronta KROS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KROS
Keros Therapeutics Inc
|
15.22 | 457.91M | 0 | -168.05M | -146.15M | -5.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-06-10 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-01-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-12-16 | Reiterato | Oppenheimer | Outperform |
| 2024-12-13 | Reiterato | H.C. Wainwright | Buy |
| 2024-12-12 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-12-12 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-11-05 | Iniziato | Jefferies | Buy |
| 2024-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-09-23 | Iniziato | Guggenheim | Buy |
| 2024-06-25 | Iniziato | Oppenheimer | Outperform |
| 2024-02-21 | Iniziato | William Blair | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-07-31 | Iniziato | Wedbush | Outperform |
| 2023-07-26 | Iniziato | BofA Securities | Buy |
| 2023-02-14 | Iniziato | Cowen | Outperform |
| 2022-10-18 | Iniziato | Truist | Buy |
| 2022-07-26 | Iniziato | BTIG Research | Buy |
| 2020-12-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-04 | Iniziato | Jefferies | Buy |
| 2020-05-04 | Iniziato | Piper Sandler | Overweight |
| 2020-05-04 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Keros Therapeutics Inc Borsa (KROS) Ultime notizie
What hedge fund activity signals for Keros Therapeutics Inc. stockJuly 2025 Pullbacks & Reliable Breakout Forecasts - newser.com
How to manage a losing position in Keros Therapeutics Inc.Product Launch & Safe Entry Zone Tips - newser.com
Will Keros Therapeutics Inc. stock rally after Fed decisionsJuly 2025 Intraday Action & Safe Entry Point Alerts - newser.com
Published on: 2025-11-02 04:38:21 - newser.com
Reversal indicators forming on Keros Therapeutics Inc. stockJuly 2025 Closing Moves & Momentum Based Trading Signals - newser.com
How interest rate cuts could boost Keros Therapeutics Inc. stockRate Hike & Breakout Confirmation Alerts - newser.com
Can volume confirm reversal in Keros Therapeutics Inc.July 2025 Action & Risk Controlled Stock Alerts - newser.com
Why Keros Therapeutics Inc. stock remains undervalued2025 Earnings Surprises & Long-Term Investment Growth Plans - newser.com
How to recover losses in Keros Therapeutics Inc. stockJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Will Keros Therapeutics Inc. stock deliver consistent dividendsPortfolio Profit Report & Low Risk Profit Maximizing Plans - newser.com
Published on: 2025-11-01 09:22:31 - newser.com
Is Keros Therapeutics Inc. stock resilient to inflationQuarterly Growth Report & AI Forecast Swing Trade Picks - newser.com
Keros Therapeutics Inc expected to post a loss of $1.05 a shareEarnings Preview - TradingView
Keros Therapeutics, Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
Keros Therapeutics (KROS) to Release Quarterly Earnings on Wednesday - MarketBeat
Is Keros Therapeutics Inc. stock attractive for income investorsJuly 2025 Closing Moves & High Accuracy Trade Alerts - newser.com
Can trapped investors hope for a rebound in Keros Therapeutics Inc.Trade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
Keros Therapeutics Stock Fell 6.4% in a Month, What Now? - Trefis
How Keros Therapeutics Inc. stock reacts to bond yieldsPortfolio Profit Report & Daily Entry Point Trade Alerts - fcp.pa.gov.br
Evaluating Keros Therapeutics Inc. with trendline analysisMarket Sentiment Summary & AI Based Trade Execution Alerts - newser.com
Published on: 2025-10-28 02:25:47 - newser.com
Keros Therapeutics Inc Azioni (KROS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):